Your browser doesn't support javascript.
loading
Study on the method to avoid infusion-site adverse events following chemotherapeutic treatment with epirubicin and fosaprepitant using immortalized human umbilical vein endothelial cells.
Yamasaki, Miho; Oda, Keisuke; Ichinose, Takashi; Mizuguchi, Marie; Tominaga, Shoko; Omoda, Kei; Mori, Nobuhiro; Maeda, Yorinobu; Nishida, Toshihiro; Murakami, Teruo.
Afiliación
  • Yamasaki M; Department of Pharmacy, Chugoku Rosai Hospital, Kure, Hiroshima 737-0193, Japan.
  • Oda K; Laboratory of Biopharmaceutics and Pharmacokinetics, Faculty of Pharmaceutical Sciences, Hiroshima International University, Kure, Hiroshima 737-0112, Japan.
  • Ichinose T; Department of Pharmacy, Chugoku Rosai Hospital, Kure, Hiroshima 737-0193, Japan.
  • Mizuguchi M; Department of Pharmacy, Chugoku Rosai Hospital, Kure, Hiroshima 737-0193, Japan.
  • Tominaga S; Department of Pharmacy, Chugoku Rosai Hospital, Kure, Hiroshima 737-0193, Japan.
  • Omoda K; Department of Pharmacy, Chugoku Rosai Hospital, Kure, Hiroshima 737-0193, Japan.
  • Mori N; Laboratory of Biopharmaceutics and Pharmacokinetics, Faculty of Pharmaceutical Sciences, Hiroshima International University, Kure, Hiroshima 737-0112, Japan.
  • Maeda Y; Laboratory of Drug Information Analytics, Faculty of Pharmacy & Pharmaceutical Sciences, Fukuyama University, Fukuyama, Hiroshima 729-0292, Japan.
  • Nishida T; Department of Diagnostic Pathology, Chugoku Rosai Hospital, Kure, Hiroshima 737-0193, Japan.
  • Murakami T; Laboratory of Biopharmaceutics and Pharmacokinetics, Faculty of Pharmaceutical Sciences, Hiroshima International University, Kure, Hiroshima 737-0112, Japan.
Oncol Lett ; 24(5): 386, 2022 Nov.
Article en En | MEDLINE | ID: mdl-36238357

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: Oncol Lett Año: 2022 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: Oncol Lett Año: 2022 Tipo del documento: Article País de afiliación: Japón